VELCADE as Maintenance Treatment in Patients With Multiple Myeloma Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT)

NCT00311337 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
61
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Wuerzburg